ROS and kidney disease in the evolution from acute phase to chronic end stage disease: A commentary on "Oxidative signaling in renal epithelium: Critical role of cPLA2 and p38SAPK"

Free Radical Biology and Medicine

Volumn 41, Issue 2, 2006, Pages 190-192

  Bergamini, Carlo M ^a   Seghieri, Giuseppe ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b PISTOIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE A2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL PROLIFERATION; DISEASE COURSE; HUMAN; KIDNEY DISEASE; KIDNEY EPITHELIUM; KIDNEY FAILURE; KIDNEY FIBROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEINURIA; SCLEROSIS; SIGNAL TRANSDUCTION; TISSUE REGENERATION;

EID: 33745276264     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.03.022     Document Type: Note

References (18)

1. Eddy A.A. Progression in chronic renal diseases. Adv. Chronic Kidney Dis. 12 (2005) 353-365
2. Remuzzi G., Benigni A., and Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J. Clin. Invest. 116 (2006) 288-296
3. Morena M., Delbosc S., Dupuy A.M., Canaud B., and Cristol J.P. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial. Int. 9 (2005) 37-46
4. Chatziantoniou C., and Dussaule J.C. Insights into the mechanisms of renal fibrosis: is it possible to achieve regression?. Am. J. Physiol. Renal Physiol. 289 (2005) F227-F234
5. Bergamini C.M., Griffin M., and Pansini F.S. Transglutaminase and vascular biology: physiopathologic implications and perspectives for therapeutic interventions. Curr. Med. Chem. 12 (2005) 2357-2372
6. Remuzzi A., Gagliardini E., Donadoni C., Fassi A., Sangalli F., Lepre M.S., Remuzzi G., and Benigni A. Effect of angiotensin II antagonism on the regression of kidney disease in the rat. Kidney Int. 62 (2002) 885-894
7. Alexander L.D., Cui X.L., Falk J.R., and Douglas J.G. Arachidonic acid directly activates members of the MAPK superfamily in rabbit proximal tubular cells. Kidney Int. 59 (2001) 2039-2053
8. de Borst M.H., Wassel L., Kelly D.J., van Goor H., and Navis G. Mitogen activated protein signalling in the kidney: target for intervention?. Signal Transduc. 6 (2006) 32-53
9. Cui X., Ding Y., Alexander L.D., Bao C., Al-Khalili O.K., Simonson M., Eaton D.C., and Douglas J.G. Oxidative signaling in renal epithelium: critical role of cPLA2 and p38SAPK. Free Radic. Biol. Med. (2006) 10.1016/j.freeradbiomed.2006.02.004 (this issue)
10. Zhang A., Ding G., Huang S., Wu Y., Pan X., Guan X., Chen R., and Yang T. c-Jun NH2-terminal kinase mediation of angiotensin II-induced proliferation of human mesangial cells. Am. J. Physiol. Renal Physiol. 288 (2005) F1118-F1124
11. Azizi M., and Menard J. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Circulation 109 (2005) 2492-2499
12. El-Atat F.A., Stas S.N., McFarlane S.I., and Sowers J.R. The relationship between hyperinsulinemia, hypertension and progressive renal disease. J. Am. Soc. Nephrol. 15 (2004) 2816-2827
13. Wang C.C., Goalstone M.L., and Draznin B. Molecular mechanisms of insulin resistance that impact cardiovascular biology. Diabetes 53 (2004) 2735-2740
14. Seghieri G., Gironi A., Mammini P., Alviggi L., De Giorgio L.A., Bartolomei G., Ignesti G., and Franconi F. Erythrocyte spermidine levels in IDDM patients. Diabetes Care 15 (1992) 543-545
15. Bachrach U., Wang Y.C., and Tabib A. Polyamines: new cues in cellular signal transduction. News Physiol. Sci. 16 (2001) 106-109
16. Sakai N., Wada T., Furuichi K., Iwata Y., Yoshimoto K., Kitagawa K., Kokubo S., Kobayashi M., Hara A., Yamahana J., Okumura T., Takasawa K., Takeda S., Yoshimura M., Kida H., and Yokoyama H. Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am. J. Kidney Dis. 45 (2005) 54-65
17. Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur. J. Clin. Invest. 34 (2004) 785-796
18. Vaziri N.D. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin. Nephrol. 24 (2004) 469-473